19 May 2013
Keywords: Cephalon, Mesoblast, Regenerative medicne, Stem cells, Parkinsons's, Alzheimer's, Cardiovascular, CNS
Article | 09 December 2010
Australia’s Mesoblast (ASX: MSB) saw its shares rocket as much as to hit a higher of A$4.45, before ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 December 2010
17 May 2013
© 2013 thepharmaletter.com